MYL2

gene product
CMH10
Thus gene encodes the regulatory light chain associated with cardiac myosin beta (or slow) heavy chain. Ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction. Mutations in this gene are associated with mid-left ventricular chamber type hypertrophic cardiomyopathy. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
386 antibodies from 35 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Proteintech Group
5 antibodies
Novus Biologicals
35 antibodies
OriGene
10 antibodies
antibodies-online
129 antibodies
Invitrogen Antibodies
13 antibodies
Abnova Corporation
7 antibodies
Atlas Antibodies
2 antibodies
NovoPro Bioscience Inc.
5 antibodies
LifeSpan BioSciences, Inc.
42 antibodies
Acris Antibodies GmbH
10 antibodies
Biorbyt
29 antibodies
Affinity Biosciences
3 antibodies
Bioworld Technology, Inc
2 antibodies
Boster Biological Technology
2 antibodies
GeneTex
9 antibodies
Creative Diagnostics
7 antibodies
St John's Laboratory
4 antibodies
Abgent
4 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
RabMAbs
4 antibodies
Aviva Systems Biology
1 antibody
Creative Biolabs
16 antibodies
MyBioSource
5 antibodies
NSJ Bioreagents
1 antibody
ProSci
1 antibody
Miltenyi Biotec
7 antibodies
RayBiotech, Inc.
2 antibodies
Bioss
3 antibodies
Cell Signaling Technology, Inc
1 antibody
Leading Biology
3 antibodies
Sigma-Aldrich
3 antibodies
EMD Millipore
1 antibody
United States Biological
15 antibodies
Abbexa
3 antibodies
Abbiotec
1 antibody